Burkina Faso vs Chile: Previously treated cases tested for RR-/MDR-TB
Burkina Faso
99.0%
in 2024
Chile
99.0%
in 2024
Burkina Faso rank
56th
Chile rank
56th
Previously treated cases tested for RR-/MDR-TB over time
- Burkina Faso
- Chile
How they compare
Burkina Faso currently reports 99.0% against 99.0% in Chile, a difference of 0.0%.
The two have swapped places 4 times across 20 shared years of data; in 2005 it was Chile ahead.
Burkina Faso ranks 56th and Chile ranks 56th of 180 countries.
Chile has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Burkina Faso | Chile | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 10.1% | 80.0% | 69.9% | Chile |
| 2010s | 45.5% | 77.7% | 32.2% | Chile |
| 2020s | 82.6% | 85.6% | 3.0% | Chile |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Burkina Faso or Chile?
- Burkina Faso, at 99.0% against 99.0% in Chile as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Burkina Faso and Chile?
- 0.0%, with Burkina Faso ahead.
- How many years of comparable data are there for Burkina Faso and Chile?
- 20 years are reported by both, from 2005 to 2024.
- How do Burkina Faso and Chile rank globally for previously treated cases tested for rr-/mdr-tb?
- Burkina Faso ranks 56th and Chile ranks 56th of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.